Prospect of a Dopamine Contribution in the Next Generation of Antidepressant Drugs: The Triple Reuptake Inhibitors

E-ISSN： 1873-5592|10|11|1069-1084

ISSN： 1389-4501

Source： Current Drug Targets, Vol.10, Iss.11, 2009-11, pp. : 1069-1084

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Triple Reuptake Inhibitors: The Next Generation of Antidepressants

Current Neuropharmacology, Vol. 6, Iss. 4, 2008-12 ,pp. : 338-343

Bentham Science Publishers

Access to resources Recommend Favorite

Is dopamine implicated in the antidepressant-like effects of selective serotonin reuptake inhibitors in the mouse forced swimming test?

By Renard Caroline Fiocco Alexandra Clenet Florence Hascoet Martine Bourin Michel

Psychopharmacology, Vol. 159, Iss. 1, 2001-12 ,pp. : 42-50

Springer Publishing Company

Access to resources Recommend Favorite

Triple Reuptake Inhibitors (“Broad Spectrum” Antidepressants)

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 2, 2007-04 ,pp. : 141-149

Bentham Science Publishers

Access to resources Recommend Favorite

Antidepressant-like actions of DOV 21,947: a ''triple'' reuptake inhibitor

By Skolnick P. Popik P. Janowsky A. Beer B. Lippa A.S.

European Journal of Pharmacology, Vol. 461, Iss. 2, 2003-02 ,pp. : 99-104

Elsevier

Access to resources Recommend Favorite

The role of dopamine in the mechanism of action of antidepressant drugs

By D'Aquila P.S. Collu M. Gessa G.L. Serra G.

European Journal of Pharmacology, Vol. 405, Iss. 1, 2000-09 ,pp. : 365-373

Elsevier

Access to resources Recommend Favorite